Financials Healthcare & Medical Investment Corporation

Equities

3455

JP3047910009

Specialized REITs

Market Closed - Japan Exchange 02:00:00 2024-05-10 EDT 5-day change 1st Jan Change
131,500 JPY -0.98% Intraday chart for Healthcare & Medical Investment Corporation -1.57% -5.94%

Valuation

Fiscal Period: January 2019 2020 2021 2022 2023 2024
Capitalization 1 22,613 42,732 41,830 46,828 58,239 47,346
Enterprise Value (EV) 1 53,166 74,258 73,188 84,167 95,776 84,631
P/E ratio 17.4 x 23.3 x 23 x 21.4 x 24.8 x 22.4 x
Yield - - - - 4.27% 4.95%
Capitalization / Revenue 5.63 x 10.6 x 10.2 x 9.88 x 11.5 x 9.71 x
EV / Revenue 13.2 x 18.4 x 17.8 x 17.7 x 18.9 x 17.4 x
EV / EBITDA 16.2 x 24.3 x 23.7 x 23.1 x 24.9 x 23.2 x
EV / FCF -1.18 x -78.1 x 44.4 x -3.75 x 35.1 x 34.9 x
FCF Yield -84.5% -1.28% 2.25% -26.6% 2.85% 2.87%
Price to Book 1.09 x 1.29 x 1.27 x 1.21 x 1.51 x 1.23 x
Nbr of stocks (in thousands) 193 311 311 357 360 360
Reference price 2 117,100 137,400 134,500 131,100 162,000 131,700
Announcement Date 19-10-30 20-10-26 21-04-28 22-10-25 23-10-30 24-04-26
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Januari 2019 2020 2021 2022 2023 2024
Net sales 1 4,016 4,046 4,116 4,742 5,070 4,877
EBITDA 1 3,278 3,060 3,086 3,648 3,853 3,649
EBIT 1 2,380 2,144 2,136 2,532 2,722 2,523
Operating Margin 59.26% 52.99% 51.9% 53.4% 53.68% 51.72%
Earnings before Tax (EBT) 1 2,092 1,834 1,820 2,200 2,347 2,119
Net income 1 2,092 1,834 1,820 2,200 2,346 2,117
Net margin 52.09% 45.33% 44.22% 46.39% 46.28% 43.42%
EPS 2 6,744 5,897 5,852 6,126 6,527 5,890
Free Cash Flow 1 -44,925 -951 1,649 -22,426 2,729 2,427
FCF margin -1,118.66% -23.5% 40.06% -472.92% 53.82% 49.76%
FCF Conversion (EBITDA) - - 53.43% - 70.82% 66.51%
FCF Conversion (Net income) - - 90.59% - 116.29% 114.62%
Dividend per Share - - - - 6,924 6,517
Announcement Date 19-10-30 20-10-26 21-04-28 22-10-25 23-10-30 24-04-26
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: January 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 2,013 2,023 2,058 2,073 2,080 2,371 2,632 2,439 2,438 2,520 2,520
EBITDA - - - - - - - - - - -
EBIT 1 1,103 1,072 1,067 1,078 1,072 1,266 1,454 1,268 1,254 1,292 1,277
Operating Margin 54.79% 52.99% 51.85% 52% 51.54% 53.37% 55.23% 52.01% 51.43% 51.27% 50.67%
Earnings before Tax (EBT) - 918 - - - - - - - - -
Net income 1 943 917 910 921 913 1,100 1,278 1,068 1,049 1,046 1,026
Net margin 46.85% 45.33% 44.22% 44.43% 43.89% 46.4% 48.57% 43.8% 43.04% 41.51% 40.71%
EPS 2 3,034 2,951 - - - - - - - 2,909 2,853
Dividend per Share 2 3,320 3,240 - - - - - - - 3,235 3,182
Announcement Date 20-03-17 20-10-26 21-03-16 21-11-15 22-03-18 22-10-25 23-03-17 23-09-15 24-03-19 - -
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: January 2019 2020 2021 2022 2023 2024
Net Debt 1 30,553 31,526 31,358 37,339 37,537 37,285
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 9.321 x 10.3 x 10.16 x 10.24 x 9.743 x 10.22 x
Free Cash Flow 1 -44,925 -951 1,649 -22,426 2,729 2,427
ROE (net income / shareholders' equity) 7.78% 5.51% 5.5% 6.13% 6.06% 5.46%
ROA (Net income/ Total Assets) 2.69% 1.95% 1.95% 2.12% 2.11% 1.95%
Assets 1 77,888 93,878 93,386 103,739 111,134 108,759
Book Value Per Share 2 107,762 106,472 106,112 108,038 107,421 107,196
Cash Flow per Share 2 6,116 5,222 5,762 3,650 4,487 5,189
Capex 1 47,008 3,250 422 24,738 184 -
Capex / Sales 1,170.52% 80.33% 10.25% 521.68% 3.63% -
Announcement Date 19-10-30 20-10-26 21-04-28 22-10-25 23-10-30 24-04-26
1JPY in Million2JPY
Estimates
  1. Stock Market
  2. Equities
  3. 3455 Stock
  4. Financials Healthcare & Medical Investment Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW